	What Constitutes Long-Duration Response?: From Withdrawal Studies to Virtual Trajectories in Parkinson's Disease. Mov Disord Onder H. PMID: 42706821 [PubMed - as supplied by publisher]
	Routine Blood Indicators Combined With Sleep Questionnaires for the Identification of Cognitive Impairment in Parkinson's Disease: A Cross-Sectional Study With a Leakage-Free Nested Modeling Framework. Brain Behav Wang Z, Lam T, Zhang S, Song C, Pei X, Zhong J, Li B, Liu G, Cui Y, Wang S. PMID: 42706737 [PubMed - indexed for MEDLINE]
	Synaptic vesicle glycoprotein 2A PET imaging in parkinsonian Î±-synucleinopathies: a systematic review. J Neurol Garrou F, Leva L, Sacchetti GM, De Natale ER, Tondo G, Comi C. PMID: 42704496 [PubMed - indexed for MEDLINE]
	Effectiveness of mindfulness meditation on balance, cognitive functions, quality of life, and falls prevention in Parkinson's disease: A systematic review. Neuropsychol Rehabil Bogahawatta P, Wijekoon A, Harini T, Wettasinghe AH. PMID: 42704301 [PubMed - as supplied by publisher]
	Feasibility and Usability of Immersive Virtual Reality Exergames for Patients With Parkinson's Disease: A Pilot Study. Ann Rehabil Med Lee SH, Yun SJ, Kim M, Oh BM, Seo HG. PMID: 42703851 [PubMed]
	Dual-Task Exercises for Dynamic Balance, Motor Function, Functional Mobility, and Dual-Tasking in Individuals With Parkinson's Disease: A Meta-Analysis With Meta-Regression. Ann Rehabil Med Winser SJ, Khan MJ, Jor A, Kannan P. PMID: 42703847 [PubMed]
	Potential Vitamin B6 Depletion During Carbidopa/Levodopa Therapy in Parkinson's Disease: A Scoping Review of Direct Evidence. Cureus Sielaff P, Lis M, Paw, Koch RR, Sucharski M, Micha, Cierpia, Puziuk M, Miko, Staranowicz A, Dziurzy, Dziurzy, Kie, Piwar H. PMID: 42703450 [PubMed]
	Drug Repurposing for Parkinson's Disease Prevention: Replication Study of Three Drugs in French Healthcare Databases. Mov Disord Saidi Y, Paakinaho A, Pylkkö E, Hartikainen S, Tolppanen AM, Elbaz A, Ahmed I, Thiébaut ACM, Courtois É. PMID: 42703031 [PubMed - as supplied by publisher]
	Convergent Vulnerability and Divergent Outcomes of the Dopaminergic System in Parkinson's and Alzheimer's Diseases. Ageing Res Rev Xi YT, Jia CX, Wang HD, Liu PY, Li P, Niu Q, Yin YL. PMID: 42702294 [PubMed - as supplied by publisher]
	A curriculum-guided unified framework for robust unsupervised domain adaptation on multi-cohort Parkinson's disease diagnosis. Quant Imaging Med Surg Shen Y, Hai J, Qiao K, Chen J, Li Y, Yan B. PMID: 42701495 [PubMed]
	Comparative Effectiveness of Cognitive Behavioral Therapy Delivery Formats on Anxiety, Depression, and Quality of Life in Parkinson's Disease: A Network Meta-Analysis. Am J Geriatr Psychiatry Li T, Zhang S, Ding X, Zhu M, Chen H, Luo Z, Wei W, Li Z. PMID: 42701077 [PubMed - as supplied by publisher]
	Physical Training in Parkinson's Disease: A Systematic Review of Neurobiological Mechanisms, Brain-Muscle Adaptations, and Implications for Personalized Rehabilitation. Neurodegener Dis Jannou A, Welter ML. PMID: 42700415 [PubMed - as supplied by publisher]
	Art, neuroplasticity, and tradition: a narrative review and conceptual perspective of Chinese woodblock printing in global art practices and Parkinson's disease neuroscience. Front Neurosci Lin K, Fang Q, Li K. PMID: 42698827 [PubMed]
	Unveiling the Distinctive Brain Functional Dynamics Between Parkinson's Disease and Progressive Supranuclear Palsy. CNS Neurosci Ther Ye C, Shi J, Fang J, Wu T, Chan P, Ma J, Ma T. PMID: 42698292 [PubMed - indexed for MEDLINE]
	Characteristics and Hospitalization Details of Patients with Advanced Parkinson's Disease Receiving Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa: Real-World First-Year Descriptive Study from Japan. Neurol Ther Baba T, Nozaki T, Toya S, Migita H, Ri K, Takeda A. PMID: 42698056 [PubMed - as supplied by publisher]
	Antibiotics and nanoparticles in Parkinson's disease: From gut microbiota dysbiosis to neuroprotection and targeted nanotherapies. Biomed Pharmacother Frangieh MR, Saad M, Fattouh N, Sawan S. PMID: 42697040 [PubMed - as supplied by publisher]
	Effects of immersive gamification technology on the physical function of people with Parkinson's disease: a scoping review. J Neural Transm (Vienna) Aguila MER, Guitones KIM, Arellano MYB, Rivera MB, Evangelista IMB, Tanglao MJB, Ting JRP, Rabano AJ, Cruz CAK, Lopez BAA, Caro JDL, Tee ML, Tee CA, Anlacan VMM, Jamora RDG. PMID: 42696108 [PubMed - as supplied by publisher]
	Development and clinical translation of smartphone-based digital biomarkers for Parkinson's disease: a structured review. J Neural Transm (Vienna) Phokaewvarangkul O, Yamutai S, Bhidayasiri R, Vateekul P, Surangsrirat D, Maetzler W, Pilotto A, Shin C, Oyama G. PMID: 42696106 [PubMed - as supplied by publisher]
	Protocols for Bedside Assessment of Autonomic Dysfunction in Parkinson's Disease and Multiple System Atrophy. J Vis Exp Mori Y, Yamahara N, Ando T, Ono Y, Kato M, Ito M, Kodama M, Kanazumi S, Shimohata T. PMID: 42695590 [PubMed - indexed for MEDLINE]
	Glycolytic Reprogramming in Parkinson's Disease: From Bioenergetic Crosstalk to Therapeutic Modulation. Med Res Rev Yi Y, Chen C, He Y, Sun YZ, Cheng R, Liu MX, Liu ZG, Zhang XL. PMID: 42695230 [PubMed - as supplied by publisher]

Articles 1 - 20 / 58758

Page 1 of 2938



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy